phenethyl isothiocyanate has been researched along with cycloheximide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavell, BE; Donlevy, AM; Packham, G; Proud, CG; Syed Alwi, SS | 1 |
| Chiao, JW; Liu, XM; Wang, LG | 1 |
2 other study(ies) available for phenethyl isothiocyanate and cycloheximide
| Article | Year |
|---|---|
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
Topics: Animals; Antineoplastic Agents; Female; Fibroblasts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Isothiocyanates; Mechanistic Target of Rapamycin Complex 1; Mice; Molecular Structure; Multiprotein Complexes; Proteins; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2012 |
Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate.
Topics: Androgen Receptor Antagonists; Anticarcinogenic Agents; Cell Line, Tumor; Cycloheximide; Humans; Isothiocyanates; Leupeptins; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen; Sp1 Transcription Factor; Transcription, Genetic | 2006 |